Practice Guidelines for Chronic Pain Management 

Unknown author(s)

Anesthesiology · 1997 · 166 citations · 1 references

Concepts

Abstract

Developed by the Task Force on Pain Management, Chronic Pain Section: Peter R. Wilson, M.B.B.S., Ph.D. (Chair), Rochester, Minnesota; Robert A. Caplan, M.D., Seattle, Washington; Richard T. Connis, Ph.D., Woodinville, Washington; Hugh C. Gilbert, M.D., Chicago, Illinois; Eric J. Grigsby, M.D., Napa, California; J. David Haddox, D.D.S., M.D., Atlanta, Georgia; Alan M. Harvey, M.D., M.B.A., Springfield, Massachusetts; Wilhelmina C. Korevaar, M.D., Bala Cynwyd, Pennsylvania; Timothy R. Lubenow, M.D., Chicago, Illinois; and Dana L. Simon, M.D., West Des Moines, Iowa.Submitted for publication December 13, 1996. Accepted for publication January 8, 1997. Supported by the American Society of Anesthesiologists, under the direction of James F. Arens, M.D., Chairman of the Ad-Hoc Committee on Practice Parameters. Approved by the House of Delegates, October 23, 1996. A list of the articles used to develop these Guidelines is available by writing to the American Society of Anesthesiologists.Address reprint requests to the American Society of Anesthesiologists, 520 North Northwest Highway, Park Ridge, Illinois 60068–2573.Click on the links below to access all the ArticlePlus for this article.Please note that ArticlePlus files may launch a viewer application outside of your web browser.Practice guidelines are systematically developed recommendations that assist the practitioner and patient in making decisions about health care. These recommendations may be adopted, modified, or rejected according to clinical needs and constraints.Practice guidelines are not intended as standards or absolute requirements. The use of practice guidelines cannot guarantee any specific outcome. Practice guidelines are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice. The Guidelines provide basic recommendations that are supported by analysis of the current literature and by a synthesis of expert opinion, open forum commentary, and clinical feasibility data (appendix).For these Guidelines, chronic pain is defined as persistent or episodic pain of a duration or intensity that adversely affects the function or well-being of the patient, attributable to any nonmalignant etiology. The Task Force has not given preference to literature based on any particular system of definition or classification of chronic pain.The purpose of these Guidelines is to 1) optimize pain control, recognizing that a pain-free state may not be achievable, 2) minimize adverse outcomes and costs, 3) enhance functional abilities and physical and psychological well-being, and 4) enhance the quality of life for patients with chronic pain.These Guidelines focus on the knowledge base, skills, and range of interventions that are the essential elements of effective management of chronic pain and pain-related problems. The Guidelines recognize that the management of chronic pain occurs within the broader context of health care, including psychosocial function and quality of life.The Guidelines recognize that all anesthesiologists may not have access to the same knowledge base, skills, or range of modalities. However, aspects of these Guidelines may be helpful to anesthesiologists who manage patients with chronic pain in a variety of practice settings.The decision to implement a particular management approach should be based on a comprehensive assessment of the patient's overall health. The Guidelines recognize that accurate diagnosis and appropriate therapies used to modify the underlying causes of pain may improve analgesia and outcome. The risks and benefits of therapies designed to modify or correct the underlying cause(s) of pain is outside the scope of these Guidelines. Although headache is included in the definition of chronic pain, these Guidelines are not specifically intended for the management of headache. The literature search was not comprehensive with respect to headache, but the general principles of these Guidelines may be applied to the management of headache.These Guidelines are intended for use by anesthesiologists and health care personnel who deliver care under the direct supervision of anesthesiologists. The Guidelines do not compare the relative effectiveness of different interventions. They are not intended to provide treatment algorithms for specific pain syndromes. Complementary therapies are beyond the scope of these Guidelines.The literature suggests that a comprehensive history and physical examination be conducted. The Task Force and panel of consultants support the conduct of a comprehensive pain-related history and physical examination.Recommendations: General Constructs. The Task Force identifies four fundamental issues that should guide a comprehensive history and physical examination of the patient with chronic pain.1. The patient's general medical condition and extent of concurrent medical and surgical diagnoses.2. Knowledge of chronic pain syndromes is a necessary prerequisite for conducting a chronic pain evaluation. Chronic pain syndromes may be related to pathology or dysfunction in one or more organ systems or to psychological conditions. In addition, knowledge of other medical or surgical conditions that may present with pain and may mimic chronic pain syndromes also is necessary.3. Knowledge of the diagnosis and management of painful crises.4. Knowledge of the diagnosis and management of medical emergencies and complications arising from the underlying cause or treatment.Elements. The Task Force identifies five essential features of a comprehensive evaluation and treatment plan (Figure 1).1. History. A complete pain history includes a general medical history with emphasis on the chronology and symptomatology of the presenting complaint. The data should include information about the onset, quality, intensity, distribution, duration, course and affective components of the pain, and details about exacerbating and relieving factors. Additional symptoms (e.g., motor, sensory, and autonomic changes) should be noted. Information regarding previous diagnostic tests, results of previous therapies, and current therapies should be reviewed by the anesthesiologist (Table 3).2. Physical examination. The physical examination should include an appropriate, directed neurologic and musculoskeletal evaluation, with attention to other systems as indicated. Not only the cause(s) of the pain, but also the effects of the pain, such as physical deconditioning, should be evaluated and recorded.3. Psychosocial evaluation. The psychosocial evaluation should include information about the presence of psychological symptoms (e.g., anxiety, depression, or anger), psychiatric disorders, personality traits or states, coping mechanisms, and the meaning of the pain. Evidence of family, vocational, or legal issues and involvement of rehabilitation agencies should be noted. The expectations of the patient, significant others, employer, attorney, and other agencies (e.g., Workers' compensation, Social Security Administration) also should be determined.4. Impression and differential diagnosis. The previous findings should be used to determine the possible etiologies and effects of the pain (Table 4).5. Treatment plan. Once a working diagnosis has been determined, a treatment plan is formulated with input from the patient, other involved professionals, and other involved persons (e.g., significant others or qualified rehabilitation counselors). Treatment and outcome goals should be discussed with the patient.The literature is supportive of the conduct of a diagnostic evaluation for chronic pain. The panel of consultants and Task Force members also support diagnostic evaluation for purposes of determining potential etiologies of chronic pain and for identification of pain sites for treatment. The use of diagnostic local anesthetic blockade is suggested by the literature and supported by the Task Force.Recommendations: Anesthesiologists treating chronic pain should have a working knowledge of the utility and interpretation of diagnostic evaluations, including diagnostic neural blockade, imaging modalities, pharmacodiagnosis, electrodiagnosis, and laboratory studies. Diagnostic evaluation is an essential addition to the history and physical examination in the evaluation of patients with chronic pain. The treatment plan, contingencies, and plan for reassessment should be formulated based on these sources of clinical data.Neural blockade with local anesthetic, including somatic and autonomic blocks, may be useful in determining the site and etiology of chronic pain. Anesthesiologists have unique skills in this area that may benefit carefully selected patients. Anesthesiologists should personally review and interpret diagnostic data when clinically indicated.There is insufficient literature to suggest that the anesthesiologist's role in counseling and coordination of care is associated with improved analgesia or other health effects. The Task Force and consultants are supportive of the effectiveness of counseling and appropriate coordination of care in improving analgesia and quality of life.Recommendations: Anesthesiologists should provide appropriate counseling of the patient regarding the pain syndrome diagnosis, treatment options, rehabilitation, and follow-up goals. In addition, the anesthesiologist should coordinate care with other health professionals, rehabilitation and vocational agencies, and social and legal entities. Longitudinal assessments of outcome should be maintained.There is insufficient literature to evaluate the effectiveness of periodic pain assessment in chronic pain management. Multiple times of measurements, fluctuating patient and disease status, and variable interventions over time are confounding factors that make useful analysis difficult. The Task Force and consultants support the contention that periodic monitoring of the effects of therapy and patient status will result in improved pain management and reduced adverse health effects from therapy.Recommendations: Accurate and complete records of pain therapies should be maintained. Reports of pain made by the patient should be the primary source of pain assessment (Figure 2) and should be obtained at periodic intervals. Periodic monitoring may include, but is not limited to, a patient's verbal report of treatment efficacy, other pain records (e.g., pain diaries), and reports of side effects associated with pain management. Analyses of aggregate outcomes are essential to continuous quality improvement of chronic pain management in the clinical setting.For these Guidelines, multidisciplinary care includes, but is not limited to 1) contributions to patient pain care by more than one health care discipline, 2) a process or program of pain care by more than one health care discipline, or 3) a combination of 1 and 2.The literature does not provide a standard definition for multidisciplinary care. The available literature was only sufficient to address multidisciplinary care on a programmatic basis. This literature is supportive of the efficacy of multidisciplinary programs in providing analgesia and improvement of health status (e.g., functional status, quality of life). The panel of consultants and Task Force members endorse multidisciplinary chronic pain management.The literature, Task Force, and consultants also support programs that emphasize the reduction or elimination of pain medications as a primary objective of therapy (i.e., through use of physical therapy, biofeedback, behavior modification, or other psychosocial techniques).Recommendations: Anesthesiologists offer a unique contribution to patient care in the context of multidisciplinary chronic pain management. Anesthesiologists should be involved in patient evaluation, provision and interpretation of diagnostic procedures, clinical pharmacology, provision of alternative drug delivery methods, provision of temporary or long-term neural blockade, and provision of neuromodulatory techniques.For these Guidelines, multimodal therapy is defined as concomitant use of separate therapeutic interventions under the direction of a single practitioner to obtain additive beneficial effects or reduction of adverse effects. Examples include, but are not limited to 1) the use of neural blockade with medications, 2) rehabilitative therapies (e.g., physical therapy) with neural blockade or medications, and 3) medications of different categories (Table 5). The literature suggests that concomitant application of separate therapeutic interventions in chronic pain management provides effective analgesia. The literature on other health effects is equivocal. The panel of consultants and Task Force members also are supportive of the efficacy of multimodality techniques for the management of chronic pain.Recommendations: Multiple modalities, such as the combined use of neural blockade, medications, or rehabilitative therapies should be considered when analgesia with acceptable adverse effects is no longer attained with single modalities. Ideally, each modality should be administered as appropriate to achieve the desired therapeutic effect. A multimodal approach may reduce the potential for adverse effects arising from either escalating frequency or dosage levels of a single modality.The literature supports the use of antidepressants for reducing chronic pain without notable adverse effects. The literature also supports the use of antidepressants for providing overall health benefits and for improving mood. The literature supports the benefits of membrane stabilizing agents (i.e., anticonvulsants) and NSAIDs for providing analgesia but is equivocal regarding other health effects. The Task Force and consultants are supportive of the use of antidepressants, membrane stabilizing agents, and NSAIDs for providing analgesic and health benefits.Recommendations: Antidepressants are useful medications for the reduction of pain and improvement of sleep. The specific agent and the dosage should be optimized for each patient. The beneficial and adverse effects should be monitored. NSAIDS and membrane stabilizing agents (e.g., anticonvulsants) also may be used for the reduction of pain. As with antidepressants, the specific agent and dosage should be optimized for each patient, with periodic monitoring of beneficial and undesirable health effects.The literature suggests that regional sympathetic blockade (e.g., lumbar sympathetic block, stellate ganglion block, intravenous regional block) is effective in providing analgesia and is equivocal regarding beneficial or adverse health effects. The Task Force and panel of consultants are supportive of the analgesic benefits of regional sympathetic blockade. The Task Force and panel of consultants are equivocal regarding potentially beneficial or adverse health effects (e.g., hypotension, hyperalgesia, sensory and motor deficit).Recommendations: The adequacy of sympathetic blockade should be objectively assessed and recorded. Appropriate sympathetic blockade by the anesthesiologist should be provided within the context of the patient's overall treatment plan. To ensure the judicious use of sympathetic blockade, periodic monitoring should be conducted to assess analgesic benefit and adverse effects (e.g., sensory or motor block; failed blockade of sympathetic outflow, especially to the upper extremity; local anesthetic toxicity; site infections).The literature suggests that locally injected corticosteroids are effective in providing analgesia. The literature is equivocal regarding other health effects. The panel of consultants support the importance of locally injected corticosteroids in improving analgesia and enhancing patient functioning and quality of life. The consultants are equivocal regarding the adverse effects of corticosteroids.Recommendations: Local injection of corticosteroids by the anesthesiologist should be provided within the context of the patient's overall treatment plan. A directed neurologic evaluation should precede the local injection of corticosteroids. Appropriate follow-up evaluation is necessary to monitor health effects, including analgesia, function, and adverse effects on local tissues and the hypothalamic-pituitary-adrenal axis.The literature is supportive of transcutaneous electrical nerve stimulation (TENS) and spinal cord stimulation (SCS) techniques in providing analgesia and is suggestive of the analgesic benefit of peripheral nerve stimulation (PNS) techniques. The literature is equivocal regarding the beneficial or adverse health effects of TENS, PNS, and SCS. The Task Force and panel of consultants are supportive of neurostimulation therapy for analgesia.Recommendations: An office or home trial of TENS should be considered as an early management option because of its low complexity and low risk. TENS also may be considered as adjunctive therapy.Peripheral nerve stimulation should be reserved for patients with a peripheral mononeuropathy who have responded to a diagnostic sequence of local neural blockade and a stimulation trial.Spinal cord stimulation should not be a first-line treatment but may be considered after failure of oral medications. SCS may be effective in the management of patients with peripheral neuropathic pain or with pain arising from the spinal cord (e.g., arachnoiditis, syringomyelia, spinal cord injury, multiple sclerosis). It should be preceded by a trial with a percutaneous electrode system.Opioid therapy for chronic pain management may be administered by several routes, the most delivery (e.g., or also may be to the (e.g., The relative of for chronic pain management was not in the these literature supports the analgesic efficacy of However, the literature suggests that use of may be associated with of adverse (e.g., and literature suggests that delivery of for chronic pain is associated with effective analgesia and is equivocal regarding adverse effects. The consultants are supportive of the analgesic benefits of therapies and are equivocal regarding adverse therapy may be considered when analgesia provided by other (e.g., is no longer to manage chronic pain. or should be administered on the of patient of should within the context of a system that provides the and of personnel to to patient needs and according to and The analgesic benefits of should be the potential adverse of long-term with for chronic pain may follow-up evaluation. A or a from with in pain management may be techniques neural (e.g., or or (e.g., or The literature suggests that and techniques provide of chronic pain and reduction in regional sympathetic adverse health effects from treatment are possible but is insufficient literature regarding the of neural blockade techniques. The Task Force and consultants are supportive of the of techniques in management and are regarding other health should be preceded by of local anesthetic, or electrical temporary blockade does not guarantee the of Although the of adverse effects of techniques is the on the patient may be adverse effects include motor, sensory, and autonomic dysfunction (e.g., pain, of control, or pain, and techniques should be used as of a comprehensive approach to pain and applied only as a after failure of other assessments of pain and other health effects should be conducted assessment of these Guidelines was based on the or These about chronic pain, and clinical A comprehensive history and physical pain or adverse effects from pain therapy, function and quality of provides and of Diagnostic evaluation neural blockade, pharmacodiagnosis, pain or adverse effects from pain therapy, function and quality of provides and of and coordination of care (i.e., pain or adverse effects from pain therapy, function and quality of provides and of and of clinical outcomes pain or adverse effects from pain therapy, function and quality of provides and of pain management pain or adverse effects from pain therapy, function and quality of provides and of pain management pain or adverse effects from pain therapy, function and quality of provides and of (e.g., antidepressants, membrane stabilizing agents, and reduce pain or reduce adverse effects from pain therapy, improve function and quality of provide and of sympathetic blockade (e.g., lumbar sympathetic block, stellate ganglion block, intravenous regional block) pain or adverse effects from pain therapy, function and quality of provides and of injection therapy pain or adverse effects from pain therapy, function and quality of provides and of therapy (i.e., transcutaneous electrical nerve stimulation peripheral nerve stimulation spinal cord stimulation pain or adverse effects from pain therapy, function and quality of provides and of therapy (i.e., drug delivery and drug pain or adverse effects from pain therapy, function and quality of provides and of techniques (i.e., and reduce pain or reduce adverse effects from pain therapy, improve function and quality of provide and of was from literature, with used when appropriate, and from open and other purposes of literature potentially clinical and of the The search a from through The search a from through than articles that related to the review of the not provide direct and A of articles direct result for each was by the outcome as either a a or The results to obtain a assessment of support for each The literature to five with and information to conduct These five pain management pain management programs that emphasize the reduction or elimination of pain medications as a primary objective of and and and therapy, drug used in the Guidelines to the of the to interventions and associated are insufficient data to provide an of the the and is in the of reports or but is insufficient to a and data a significant and outcome and data are applied to continuous and an was applied to combined used as 1) The based on of the from the and 2) the providing of the by each of the standard by the of the A based on the for results was available for use with outcome frequency An acceptable was at and was through assessment of for of the conducted to the To for potential a was for each combined search for was and no for results of the combined are in levels from the combined for analgesic efficacy significant for pain management pain management programs with emphasis on pain reduction or and and from to levels from the combined for beneficial effects significant for pain management pain management pain and for beneficial effects from to a separate analysis was conducted state findings to determine any state effects associated with the use of these medications. levels for this not significant data not available in the literature to conduct on these for of and for and that the provided of and for of significant for and and health for of significant for and health and findings for analgesic efficacy for may the of used in the analysis 5). findings for analgesic efficacy of and may either the differential of the medications or that the analysis used medications primary purpose was not specifically intended for pain management. findings for and suggest that the findings be for in therapeutic medications, or patient in multidisciplinary pain Task Force members and was by levels a for 1) of 2) of 3) and 4) literature for 1) 2) 3) and 4) literature These levels of findings of the literature by the of Task Force members and by of the of a panel of consultants with in chronic pain management The of was of The of consultants each is in in supportive of the (i.e., that provided analgesic reduced of adverse improved function and quality of and issues for the Guidelines to feasibility of these Guidelines clinical practice was assessed by an of the chronic pain The of was The of patients by the consultants was to be for feasibility of of the Guidelines as of these consultants that of the Guidelines not result in the to or The who that be of of the Guidelines to be for the of improved nerve and consultants to of the clinical the Guidelines The of consultants no associated with each was as comprehensive history and physical diagnostic evaluation, counseling and coordination of care, monitoring and of multidisciplinary pain multimodality pain regional sympathetic blockade, therapy, neurostimulation therapy, therapy, and of the that the Guidelines have no on the time on a that the Guidelines reduce the of time all the in the of time on a was the of who an in time on a the was with in the used in these Guidelines information by writing Peter R. Wilson, Rochester,

References

1